Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Boston Scientific and Surgi-Vision pen MRI-safe technology agreement

Boston Scientific : 15 April, 2008  (Company News)
Boston Scientific and Surgi-Vision have reached a licensing and development arrangement for magnetic resonance imaging (MRI)-safe technology.
Physician implanters have consistently mentioned MRI-safe cardiac devices as a primary unmet clinical need. Under the arrangement, Boston Scientific will gain access to Surgi- Vision's development capabilities and will obtain a license to Surgi-Vision's intellectual property for potential use in its implantable cardiac devices.

The two companies will work jointly to develop a commercial application of Surgi-Vision's technology.

'Surgi-Vision is thrilled to have entered into this agreement with Boston Scientific as it represents a tremendous opportunity for both companies,' said Kimble Jenkins, chief executive officer of Surgi-Vision. 'Our company is a leader in the development of MRI-safe technologies, and we look forward to applying our expertise to the field of cardiac rhythm management devices with Boston Scientific.'

'This agreement with Surgi-Vision is consistent with our vision of providing physicians with the highest quality products for their patients,' said Fred Colen, executive vice president, operations and technology, Boston Scientific Cardiac Rhythm Management. 'Surgi-Vision's technology, when combined with our history of innovation, should move development of MRI-safe cardiac devices closer to reality.'

Boston Scientific and Surgi-Vision entered into a separate licensing and development agreement, in the area of neuromodulation, in December 2005.

Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo